These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34192127)

  • 1. Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19.
    Garrido M; Pereira Guedes T; Alves Silva J; Falcão D; Novo I; Archer S; Rocha M; Maia L; Sarmento-Castro R; Pedroto I
    GE Port J Gastroenterol; 2021 Jan; 158(4):1-12. PubMed ID: 34192127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients.
    Ponziani FR; Del Zompo F; Nesci A; Santopaolo F; Ianiro G; Pompili M; Gasbarrini A;
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1060-1068. PubMed ID: 32628793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network.
    Hundt MA; Deng Y; Ciarleglio MM; Nathanson MH; Lim JK
    Hepatology; 2020 Oct; 72(4):1169-1176. PubMed ID: 32725890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mortality of hospitalized patients with COVID-19 and non-cirrhotic chronic liver disease: a retrospective multi-center study.
    Wu PJ; Feng IC; Lai CC; Ho CH; Kan WC; Sheu MJ; Kuo HT
    PeerJ; 2023; 11():e16582. PubMed ID: 38077441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term outcomes of patients with chronic liver disease hospitalised with COVID-19.
    Grgurevic I; Lucijanić M; Pastrovic F; Barisic Jaman M; Tjesic Drinkovic I; Zelenika M; Milosevic M; Medic B; Kardum D; Bokun T; Luksic I; Piskac Zivkovic N; Keres T; Grabovac V; Persec J; Barsic B
    Intern Med J; 2022 Nov; 52(11):1891-1899. PubMed ID: 35555962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease.
    Hartl L; Haslinger K; Angerer M; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M
    Hepatology; 2022 Dec; 76(6):1563-1575. PubMed ID: 35596929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients.
    Krishnan A; Prichett L; Tao X; Alqahtani SA; Hamilton JP; Mezey E; Strauss AT; Kim A; Potter JJ; Chen PH; Woreta TA
    World J Gastroenterol; 2022 Feb; 28(5):570-587. PubMed ID: 35316959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities.
    Shafran N; Issachar A; Shochat T; Shafran IH; Bursztyn M; Shlomai A
    JHEP Rep; 2021 Jun; 3(3):100258. PubMed ID: 33644724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
    Kumar-M P; Mishra S; Jha DK; Shukla J; Choudhury A; Mohindra R; Mandavdhare HS; Dutta U; Sharma V
    Hepatol Int; 2020 Sep; 14(5):711-722. PubMed ID: 32623633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Nonalcoholic Fatty Liver Disease (NAFLD) on COVID-19: A Single-Center Study of 3983 Patients With Review of Literature.
    Nath P; Kumar R; Mallick B; Das S; Anand A; Panigrahi SC; Duseja A; Acharya SK; Chawla YK; Praharaj DL
    Cureus; 2022 Jul; 14(7):e26683. PubMed ID: 35949776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis.
    Sharma A; Jaiswal P; Kerakhan Y; Saravanan L; Murtaza Z; Zergham A; Honganur NS; Akbar A; Deol A; Francis B; Patel S; Mehta D; Jaiswal R; Singh J; Patel U; Malik P
    Ann Hepatol; 2021; 21():100273. PubMed ID: 33075578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of COVID-19 on the liver: The experience of a single center.
    Liakina V; Stundiene I; Milaknyte G; Bytautiene R; Reivytyte R; Puronaite R; Urbanoviciute G; Kazenaite E
    World J Gastroenterol; 2022 Oct; 28(39):5735-5749. PubMed ID: 36338891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver manifestations in COVID-19 and the influence of pre-existing liver disease in the course of the infection.
    Guerra Veloz MF; Cordero Ruiz P; Ríos-Villegas MJ; Del Pino Bellido P; Bravo-Ferrer J; Galvés Cordero R; Cadena Herrera ML; Vías Parrado C; Bellido Muñoz F; Vega Rodríguez F; Caunedo Álvarez Á; Rodríguez-Baño J; Carmona Soria I
    Rev Esp Enferm Dig; 2021 Feb; 113(2):103-109. PubMed ID: 33393329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 infection in patients with autoimmune hepatitis.
    Marjot T; Buescher G; Sebode M; Barnes E; Barritt AS; Armstrong MJ; Baldelli L; Kennedy J; Mercer C; Ozga AK; Casar C; Schramm C; ; Moon AM; Webb GJ; Lohse AW
    J Hepatol; 2021 Jun; 74(6):1335-1343. PubMed ID: 33508378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the impact of chronic corticosteroid therapy on critical care outcomes of COVID-19 patients with and without history of chronic liver disease.
    Liaquat H; Shupp B; Rollins S; Schneider Y; Matin A
    Sci Rep; 2021 Sep; 11(1):19245. PubMed ID: 34584170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Liver Disease and Cirrhosis are Associated with Worse Outcomes Following SARS-CoV-2 Infection.
    Wong RJ; Zhang Y; Thamer M
    J Clin Exp Hepatol; 2023; 13(4):592-600. PubMed ID: 36777086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study.
    Simon TG; Hagström H; Sharma R; Söderling J; Roelstraete B; Larsson E; Ludvigsson JF
    BMC Gastroenterol; 2021 Nov; 21(1):439. PubMed ID: 34814851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of mortality in people with chronic liver diseases hospitalized for Coronavirus disease of 2019 (COVID-19) in a tertiary hospital in Lombardy, Italy.
    Ranzenigo M; Ceccarelli D; Galli L; Bertoni C; Siribelli A; Messina E; Hasson H; Lolatto R; Castagna A; Uberti-Foppa C; Morsica G
    New Microbiol; 2023 Sep; 46(3):296-302. PubMed ID: 37747475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.